Edwards Lifesciences (EW) News Today $74.81 +0.88 (+1.19%) (As of 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Jim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback?December 20 at 6:07 PM | insidermonkey.comEdwards Lifesciences: Competitive Pressures and Valuation Concerns Lead to Sell RatingDecember 18 at 9:40 PM | markets.businessinsider.comDeutsche Bank Sticks to Its Buy Rating for Edwards Lifesciences (EW)December 18 at 9:40 PM | markets.businessinsider.comBrokerages Set Edwards Lifesciences Co. (NYSE:EW) Target Price at $78.65December 18 at 3:19 AM | americanbankingnews.comEdwards Lifesciences (NYSE:EW) Rating Increased to Buy at Bank of AmericaDecember 18 at 2:33 AM | americanbankingnews.comAssessing Edwards Lifesciences: Insights From 20 Financial AnalystsDecember 17 at 12:10 PM | benzinga.comB of A Securities Upgrades Edwards Lifesciences (EW)December 17 at 12:10 PM | msn.comEdwards Lifesciences Co. (NYSE:EW) Shares Purchased by Franklin Resources Inc.Franklin Resources Inc. boosted its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 2.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,196,059 shares of the meDecember 17 at 5:00 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) VP Daniel J. Lippis Sells 2,500 SharesDecember 17 at 4:35 AM | insidertrades.comMML Investors Services LLC Has $2.25 Million Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)MML Investors Services LLC decreased its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 65.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 34,115 shares of the medical research company's stocDecember 17 at 3:52 AM | marketbeat.comZacks Research Issues Optimistic Forecast for EW EarningsDecember 17 at 1:55 AM | americanbankingnews.comDaniel J. Lippis Sells 2,500 Shares of Edwards Lifesciences Co. (NYSE:EW) StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) VP Daniel J. Lippis sold 2,500 shares of the business's stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $74.08, for a total value of $185,200.00. Following the sale, the vice president now owns 23,189 shares in the company, valued at $1,717,841.12. The trade was a 9.73 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.December 16, 2024 | marketbeat.comEdwards Lifesciences upgraded to Buy from Neutral at BofADecember 16, 2024 | markets.businessinsider.comBank of America Upgrades Edwards Lifesciences (NYSE:EW) to "Buy"Bank of America upgraded shares of Edwards Lifesciences from a "neutral" rating to a "buy" rating in a research note on Monday.December 16, 2024 | marketbeat.comZacks Research Analysts Increase Earnings Estimates for EWEdwards Lifesciences Co. (NYSE:EW - Free Report) - Stock analysts at Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for shares of Edwards Lifesciences in a report issued on Wednesday, December 11th. Zacks Research analyst R. Department now forecasts that the medical resDecember 16, 2024 | marketbeat.comSynovus Financial Corp Cuts Stake in Edwards Lifesciences Co. (NYSE:EW)Synovus Financial Corp trimmed its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 22.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 49,385 shares of the medical research company's stock after selling 13,938 shares during thDecember 15, 2024 | marketbeat.comTD Private Client Wealth LLC Reduces Position in Edwards Lifesciences Co. (NYSE:EW)TD Private Client Wealth LLC decreased its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 84.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,346 shares of the medical research company's stockDecember 15, 2024 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Given Consensus Rating of "Hold" by AnalystsShares of Edwards Lifesciences Co. (NYSE:EW - Get Free Report) have been given a consensus rating of "Hold" by the twenty-six analysts that are presently covering the stock, MarketBeat reports. Sixteen investment analysts have rated the stock with a hold rating and ten have given a buy rating to tDecember 15, 2024 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Stock Holdings Trimmed by M&T Bank CorpM&T Bank Corp decreased its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 24.7% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 39,220 shares of the medical research company's stock after selling 12,841 shaDecember 14, 2024 | marketbeat.comZacks Research Issues Positive Forecast for EW EarningsDecember 14, 2024 | americanbankingnews.comEW DEADLINE TODAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important December 13 Deadline in Securities Class Action – EWDecember 13, 2024 | globenewswire.comFaruqi & Faruqi Reminds Edwards Lifesciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EWDecember 13, 2024 | investing.comEdwards Lifesciences Co. (NYSE:EW) Stock Position Raised by Peapack Gladstone Financial CorpPeapack Gladstone Financial Corp lifted its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 108.0% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 293,758 shares of the medical research company's stock after acquiring anDecember 13, 2024 | marketbeat.comQ3 EPS Estimate for Edwards Lifesciences Lifted by AnalystEdwards Lifesciences Co. (NYSE:EW - Free Report) - Stock analysts at Zacks Research boosted their Q3 2025 earnings per share (EPS) estimates for shares of Edwards Lifesciences in a note issued to investors on Wednesday, December 11th. Zacks Research analyst R. Department now forecasts that the meDecember 13, 2024 | marketbeat.comWorld Investment Advisors LLC Grows Position in Edwards Lifesciences Co. (NYSE:EW)World Investment Advisors LLC boosted its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 1,660.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 72,277 shares of the medical research company's stocDecember 13, 2024 | marketbeat.comTeachers Retirement System of The State of Kentucky Boosts Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Teachers Retirement System of The State of Kentucky grew its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 43.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 138,December 13, 2024 | marketbeat.comLevi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EWDecember 13, 2024 | prnewswire.comEdwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Citigroup Analyst SaysDecember 13, 2024 | americanbankingnews.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences CorporationDecember 12, 2024 | tmcnet.comEW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitDecember 12, 2024 | globenewswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)December 12, 2024 | businesswire.comFaruqi & Faruqi Reminds Edwards Lifesciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EWDecember 12, 2024 | prnewswire.comEdwards Lifesciences (EW) Faces Investor Class Action Lawsuit Over TAVM Platform Disclosures, Deadline Pending – Hagens BermanDecember 12, 2024 | globenewswire.com48,084 Shares in Edwards Lifesciences Co. (NYSE:EW) Bought by Virtu Financial LLCVirtu Financial LLC acquired a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 48,084 shares of the medicDecember 12, 2024 | marketbeat.comEW COURT DEADLINE TOMORROW: BFA Law Alerts Edwards Lifesciences Investors of Tomorrow's December 13 Securities Fraud Class Action Deadline (NYSE:EW)December 12, 2024 | globenewswire.comINVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - EWDecember 12, 2024 | globenewswire.comNeo Ivy Capital Management Purchases New Shares in Edwards Lifesciences Co. (NYSE:EW)Neo Ivy Capital Management acquired a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 11,002 shares of tDecember 12, 2024 | marketbeat.comEdwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before December 13, 2024 to Discuss Your Rights - EWDecember 12, 2024 | prnewswire.comEdwards Lifesciences Co. (NYSE:EW) Shares Bought by Geode Capital Management LLCGeode Capital Management LLC lifted its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 2.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,521,147 shares of the medical research company's stoDecember 12, 2024 | marketbeat.comNomura Asset Management Co. Ltd. Reduces Stock Position in Edwards Lifesciences Co. (NYSE:EW)Nomura Asset Management Co. Ltd. decreased its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 27.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 201,503 shares of the medical research compaDecember 12, 2024 | marketbeat.comEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud LawsuitDecember 11, 2024 | prnewswire.comEW Deadline: Rosen Law Firm Urges Edwards Lifesciences Corporation (NYSE: EW) Stockholders with Large Losses to Contact the Firm for Information About Their RightsDecember 11, 2024 | businesswire.comEW Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation (EW) Investors of Filing Deadline in Class Action LawsuitDecember 11, 2024 | globenewswire.comLevi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EWDecember 11, 2024 | globenewswire.comEdwards Lifesciences (EW) Receives a Hold from Truist FinancialDecember 11, 2024 | markets.businessinsider.comPublic Employees Retirement System of Ohio Has $19.81 Million Stake in Edwards Lifesciences Co. (NYSE:EW)Public Employees Retirement System of Ohio lifted its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 8.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 300,202 sharesDecember 11, 2024 | marketbeat.comKovitz Investment Group Partners LLC Acquires 9,093 Shares of Edwards Lifesciences Co. (NYSE:EW)Kovitz Investment Group Partners LLC raised its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 65.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,039 shares of the mDecember 11, 2024 | marketbeat.comStifel Financial Corp Has $15.36 Million Stake in Edwards Lifesciences Co. (NYSE:EW)Stifel Financial Corp grew its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 11.9% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 232,738 shares of the medical research company's stock after buying an additional 24,731 shares duriDecember 11, 2024 | marketbeat.comEDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the FirmDecember 10, 2024 | globenewswire.comGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW)December 10, 2024 | globenewswire.com Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. EW Media Mentions By Week EW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EW News Sentiment▼0.590.62▲Average Medical News Sentiment EW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EW Articles This Week▼2720▲EW Articles Average Week Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Stryker News Boston Scientific News Medtronic News Becton, Dickinson and Company News IDEXX Laboratories News ResMed News DexCom News STERIS News Insulet News Hologic News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:EW) was last updated on 12/20/2024 by MarketBeat.com Staff From Our PartnersDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredMusk threatens Liberal’s fake “energy crisis”Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people a...Porter & Company | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
